NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Idelalisib for treating follicular lymphoma that is refractory to 2 prior treatments (terminated appraisal) - NICE TAG TA328

Idelalisib for treating follicular lymphoma that is refractory to 2 prior treatments (terminated appraisal) - NICE TAG TA328

NICE is unable to make a recommendation about the use in the NHS of idelalisib for treating follicular lymphoma that is refractory to 2 prior lines of treatment because no evidence submission was received from Gilead Sciences for the technology.

http://www.nice.org.uk/guidance/ta328

Site by Devopa
© Copyright 2020 NHS. All rights reserved.